Elizabeth Dudnik
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Durvalumab (MEDI4736) Plus Platinum-based Chemotherapy in Advanced LCNEC: a Pilot Phase II Study (NCT05262985) | Elizabeth Dudnik | 2022-01-31 |
Track Elizabeth Dudnik automatically
Every clearance here is in the API, with alerts when new ones post.